Title: Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal cytoreductive surgery
Abstract: Objective: Intraperitoneal (IP) chemotherapy following neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS) is feasible; however, the effect on survival remains unclear. This study compared the outcomes of patients treated with IP chemotherapy with those receiving intravenous (IV) chemotherapy alone following NACT and optimal IDS.
Publication Year: 2017
Publication Date: 2017-06-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot